CRISPR Therapeutics AG (CRSP) Interest Coverage Ratio (QoQ) (2016 - 2025)
CRISPR Therapeutics AG (CRSP) Interest Coverage Ratio (QoQ) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | CRISPR Therapeutics AG | 4.57 Bn | 2.12 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -158.05% |
| Dec 31, 2024 | 99.04% |
| Sep 30, 2024 | -1,018.08% |
| Jun 30, 2024 | 13.55% |
| Mar 31, 2024 | -16,304.31% |
| Dec 31, 2023 | 101.63% |
| Sep 30, 2023 | -85.86% |
| Jun 30, 2023 | -65.99% |
| Mar 31, 2023 | -48.41% |
| Dec 31, 2022 | 50.35% |
| Sep 30, 2022 | 8.85% |
| Jun 30, 2022 | 13.10% |
| Mar 31, 2022 | -1,465.39% |
| Dec 31, 2021 | 99.51% |
| Sep 30, 2021 | -113.61% |
| Jun 30, 2021 | 577.29% |
| Mar 31, 2021 | -172,562.71% |
| Dec 31, 2020 | 99.98% |
| Dec 31, 2019 | 356.39% |
| Sep 30, 2019 | 455.32% |